Not independent
Tenure on this board
11.7 yrs
Also a director at
Engene Therapeutics Inc (ENGN)
8 nominees · 3 ballot items.
Ratify PwC as auditors; advisory approval of executive compensation; approve amendment to increase authorized common shares from 150,000,000 to 300,000,000.
Ratify the Audit Committee’s selection of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year ending March 31, 2027.
Advisory vote to approve, on a non-binding basis, the compensation of the Company’s named executive officers for fiscal year ended March 31, 2026.
Approve amendment to the Third Amended and Restated Certificate of Incorporation to increase authorized common stock from 150,000,000 to 300,000,000 shares.
Management requests shareholder approval to amend the Company’s certificate of incorporation to increase the authorized common shares from 150 million to 300 million (total authorized shares 310 million including preferred). The board argues this provides flexibility for capital raises, strategic transactions, equity compensation grants, and other corporate needs without immediate dilution; notes no current specific plans beyond ordinary-course issuances and at-the-market program; and highlights that approval requires a majority of votes cast and that if approved the board can issue shares without further shareholder approval subject to Nasdaq rules. The board recommends a FOR vote, stating the increase is in the best interests of the company and stockholders to support growth, strategic flexibility, and talent retention.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BAKER BROS. ADVISORS LP | 11.72% | 11,045,336 | $122M |
| 2 | RTW INVESTMENTS, LP | 7.87% | 7,411,581 | $82M |
| 3 | Ridgeback Capital Investments L.P. | 7.76% | 7,310,656 | $81M |
| 4 | STATE STREET CORP | 4.71% | 4,440,144 | $49M |
| 5 | MONTANOVA CAPITAL, LLC | 4.66% | 4,389,836 | $49M |
| 6 | GOLDMAN SACHS GROUP INC | 4.63% | 4,363,266 | $48M |
| 7 | Boxer Capital Management, LLC | 4.23% | 3,983,000 | $44M |
| 8 | BlackRock, Inc. | 4.04% | 3,809,155 | $42M |
| 9 | BlackRock, Inc. | 3.34% | 3,144,860 | $35M |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 3.07% | 2,896,004 | $32M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.